Total Medical devices industry cross border venture financing deals worth $2bn were announced globally in Q2 2022, led by $300m venture financing of Biofourmis, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 32.3% over the previous quarter and a drop of 47.01% when compared with the last four-quarter average, which stood at $3.68bn.

Comparing cross border deals value in different regions of the globe, North America held the top position, with total announced deals worth $982.44m in the period. At the country level, the US topped the list in terms of deal value at $952.44m.

In terms of volumes, Europe emerged as the top region for Medical devices industry cross border venture financing deals globally, followed by North America and then Asia-Pacific.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

The top country in terms of cross border venture financing deals activity in Q2 2022 was the US with 23 deals, followed by the UK with seven and China with six.

In 2022, at the end of , cross border venture financing deals worth $2bn were announced globally in Medical devices industry, marking a decrease of 36.4% year on year.

Cross Border venture financing deals in Medical devices industry in Q2 2022: Top deals

The top five cross border venture financing deals in Medical devices industry accounted for 38.01% of the overall value during Q2 2022.

The combined value of the top five cross border venture financing deals stood at $740m, against the overall value of $2bn recorded for the quarter.

The top five Medical devices industry cross border venture financing deals of Q2 2022 tracked by GlobalData were:

1) CVS Health, Export Development Bank of Iran, General Atlantic, Mass Mutual Ventures, Openspace Ventures, Sequoia Capital and SoftBank Vision Fund II $300m venture financing deal with Biofourmis

2) The $150m venture financing of BostonGene by Impact Investment Partners,Japan Industrial Partners and NEC

3) Alpha Intelligence Capital,CDIB Capital and TCMI $110m venture financing deal with Aidoc Medical

4) The $100m venture financing of Viz.ai by Charles River Ventures, GV Management Co, Insight Partners, Kleiner Perkins, Scale Ventures, Sozo Ventures, Susa Ventures, Threshold Ventures and Tiger Global Management

5) Advent Life Sciences, British Patient Capital, Eight Roads Ventures, Emerson Collective, F Prime Capital, Global ventures, Maverick Ventures Israel, Minderoo Foundation, Mubadala Investment, Questa Capital Management and SoftBank Vision Fund 2 $80m venture financing deal with Proximie